These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 5819636)

  • 41. Muscarinic cholinergic binding in rat brain.
    Yamamura HI; Snyder SH
    Proc Natl Acad Sci U S A; 1974 May; 71(5):1725-9. PubMed ID: 4151898
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The effect of atropine, quinuclidinyl benzilate and their antidote tetrahydroaminoacridine on adhesion and spreading in cells cultured in vitro].
    Kolárová J; Hroch M
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1988; 31(4):459-65. PubMed ID: 3249932
    [No Abstract]   [Full Text] [Related]  

  • 43. Synthesis of iodine-125 labeled 3-quinuclidinyl 4'-iodobenzilate.
    Kabalka GW; Gai YZ; Mathur S
    Int J Rad Appl Instrum B; 1989; 16(4):359-60. PubMed ID: 2777574
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Binding of [3H]quinuclidinyl benzilate to regions of rat pituitary and hypothalamus.
    Hoover DB; Hancock JC; Talley NS
    Brain Res Bull; 1981 Mar; 6(3):209-11. PubMed ID: 7225899
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cholinergic muscarinic receptor in synaptosomal membranes. Heterogeneity of binding sites for L-[3H]quinuclidinyl benzilate.
    Aguilar JS; Salas PJ; De Robertis E
    Mol Pharmacol; 1982 Sep; 22(2):304-9. PubMed ID: 7144732
    [No Abstract]   [Full Text] [Related]  

  • 46. Effects of deanol, choline and its metabolites on binding of [3H]quinuclidinyl benzilate to rat brain membranes.
    Haubrich DR; Risley EA; Williams M
    Biochem Pharmacol; 1979 Dec; 28(24):3673-4. PubMed ID: 533566
    [No Abstract]   [Full Text] [Related]  

  • 47. [Analysis and stability of propiverine hydrochloride (Mictonorm)].
    Göber B; Dressler K; Franke P; Alder L
    Pharmazie; 1986 Dec; 41(12):840-2. PubMed ID: 3575385
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Syntheses and biological properties of chiral fluoroalkyl quinuclidinyl benzilates.
    Kiesewetter DO; Silverton JV; Eckelman WC
    J Med Chem; 1995 May; 38(10):1711-9. PubMed ID: 7752195
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Altered [3H]quinuclidinyl benzilate binding in the striatum of rats following chronic cholinesterase inhibition with diisopropylfluorophosphate.
    Ehlert FJ; Kokka N; Fairhurst AS
    Mol Pharmacol; 1980 Jan; 17(1):24-30. PubMed ID: 7383017
    [No Abstract]   [Full Text] [Related]  

  • 50. Kindled seizures selectively reduce a subpopulation of [3H]quinuclidinyl benzilate binding sites in rat dentate gyrus.
    Savage DD; McNamara JO
    J Pharmacol Exp Ther; 1982 Sep; 222(3):670-3. PubMed ID: 7108770
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vivo competition studies with analogues of 3-quinuclidinyl benzilate.
    Eckelman WC; Grissom M; Conklin J; Rzeszotarski WJ; Gibson RE; Francis BE; Jagoda EM; Eng R; Reba RC
    J Pharm Sci; 1984 Apr; 73(4):529-34. PubMed ID: 6327965
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reduced [3H]quinuclidinyl benzilate binding to muscarinic receptors in disulfoton-tolerant mice.
    Costa LG; Schwab BW; Hand H; Murphy SD
    Toxicol Appl Pharmacol; 1981 Sep; 60(3):441-50. PubMed ID: 7292482
    [No Abstract]   [Full Text] [Related]  

  • 53. The affinity of [3H]quinuclidinyl benzilate and some other radioligands for glass microfiber and cellulose filters in some common liquid scintillation solvents.
    Dawson RM
    Anal Biochem; 1984 Jun; 139(2):493-501. PubMed ID: 6476385
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The schedule dependent effects of 3-quinuclidinyl benzilate on operant behavior in the rat.
    Liu WF; Beaton JM
    Pharmacol Biochem Behav; 1986 Dec; 25(6):1191-4. PubMed ID: 3809220
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization of muscarinic cholinergic receptors in the lower esophageal sphincter of the cat: binding of [3H]quinuclidinyl benzilate.
    Rimele TJ; Rogers WA; Gaginella TS
    Gastroenterology; 1979 Dec; 77(6):1225-34. PubMed ID: 499710
    [No Abstract]   [Full Text] [Related]  

  • 56. Light microscopic autoradiographic localization of [3H]pirenzepine and [3H](-)quinuclidinyl benzilate binding in human stellate ganglia.
    Yamamura HI; Watson M; Wamsley JK; Johnson PC; Roeske WR
    Life Sci; 1984 Aug; 35(7):753-7. PubMed ID: 6547993
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacologic identification of muscarinic receptors in the pylorus of the cat by binding of [3H]-quinuclidinyl benzilate.
    Gaginella TS; Rimele TJ; O'Dorisio TM; Dorff RJ
    Life Sci; 1980 May; 26(19):1599-608. PubMed ID: 7382732
    [No Abstract]   [Full Text] [Related]  

  • 58. Mass spectrometry as an aid in the detection and identification of piperidyl benzilates and related glycolates.
    Petersen BA; Vouros P; Parker JM; Karger BL
    J Forensic Sci; 1976 Apr; 21(2):279-90. PubMed ID: 1262828
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Relations between muscimol, quinuclidinyl benzilate and nicotine binding sites in brain after very long treatment with ethanol in rats.
    Nordberg A; Wahlström G; Eriksson B
    Eur J Pharmacol; 1985 Sep; 115(2-3):301-4. PubMed ID: 4065210
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The crystal structure of coclaurine hydrobromide monohydrate and the absolute configuration of coclaurine.
    Fridrichsons J; Mathieson AM
    Tetrahedron; 1968 Sep; 24(17):5785-9. PubMed ID: 5713420
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.